Cholesterol Combo Therapy Will Likely Be More Prominent In ATP IV
Executive Summary
Treating cholesterol with a combination of statins and fibrates, niacin, or bile acid sequestrants may play a larger role in the next round of Adult Treatment Panel guidelines.
You may also be interested in...
Schering-Plough Zetia Could Be More Important Growth Product Than Claritin
Schering-Plough's cholesterol agent Zetia could be an even larger growth driver than Claritin, CEO Richard Kogan told analysts at the company's annual meeting on July 16
Schering-Plough Zetia Could Be More Important Growth Product Than Claritin
Schering-Plough's cholesterol agent Zetia could be an even larger growth driver than Claritin, CEO Richard Kogan told analysts at the company's annual meeting on July 16
Cholesterol Therapy Guidelines Stress Need To Consider Cost, Treat To Goal
The National Cholesterol Education Program treatment guidelines encourage physicians to restrict drug therapy only to high risk patients - but expand the definition of high risk to include as many as 36 mil. people in the U.S.